Cheyne Capital Management (Uk) LLP Orgenesis Inc. Transaction History

Cheyne Capital Management (Uk) LLP

  • $26.1 Million
  • Q4 2023

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 08, 2019
SELL
$3.86 - $5.2 $150,540 - $202,800
-39,000 Closed
0 $0
Q4 2018

Feb 05, 2019
BUY
$3.88 - $7.46 $151,320 - $290,940
39,000 New
39,000 $183,000

Others Institutions Holding ORGS

# of Institutions
2
Shares Held
134K
Call Options Held
0
Put Options Held
0
View Full List

About Orgenesis Inc.

ORGS Quotes by TradingView
  • Ticker ORGS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,545,800
  • Market Cap $27.8M
  • Description
  • Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics that are processed and produced in closed automated POCare technology systems across a collaborative POCare network. It focuses on autologous therapies, ...
More about ORGS
Track This Portfolio

Track Cheyne Capital Management (Uk) LLP Portfolio

Follow Cheyne Capital Management (Uk) LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cheyne Capital Management (Uk) LLP, based on Form 13F filings with the SEC.

News

Stay updated on Cheyne Capital Management (Uk) LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email